Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment...
Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders (USPTO 11903910)
About this item
Full title
Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders (USPTO 11903910)
Publisher
NewsRX LLC
Journal title
Mental Health Weekly Digest, 2024, p.1091
Language
English
Formats
Publication information
Publisher
NewsRX LLC
Subjects
More information
Alternative Titles
Full title
Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders (USPTO 11903910)
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A785947243
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A785947243
Other Identifiers
ISSN
1543-6616
How to access this item
Log in as a Library member